{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T06:59:25Z","timestamp":1648537165956},"reference-count":27,"publisher":"Japan Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1507\/endocrj.ej15-0378","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T22:03:05Z","timestamp":1443823385000},"page":"1077-1082","source":"Crossref","is-referenced-by-count":1,"title":["Exponential increase of glutamic acid decarboxylase (GAD) antibody titer after initiating and stopping insulin in a patient with slowly progressive type 1 diabetes"],"prefix":"10.1507","volume":"62","author":[{"given":"Akihiro","family":"Nishimura","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Nagasawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Okubo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan"},{"name":"Okinaka Memorial Institute for Medical Research, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Okinaka Memorial Institute for Medical Research, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumichi","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan"},{"name":"Okinaka Memorial Institute for Medical Research, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, et al. (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. <i>Nature<\/i> 347:151-156.","DOI":"10.1038\/347151a0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, et al. (1995) Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. <i>Diabetologia<\/i> 38:816-822.","DOI":"10.1007\/s001250050358"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. <i>Lancet<\/i> 2:1279-1283.","DOI":"10.1016\/S0140-6736(74)90140-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lan MS, Wasserfall C, Maclaren NK, Notkins AL (1996) IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. <i>Proc Natl Acad Sci U S A<\/i> 93:6367-6370.","DOI":"10.1073\/pnas.93.13.6367"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, et al. (1998) Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. <i>Diabetes<\/i> 47:1857-1866.","DOI":"10.2337\/diabetes.47.12.1857"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kobayashi T, Nakanishi K, Okubo M, Murase T, Kosaka K (1996) GAD antibodies seldom disappear in slowly progressive IDDM. <i>Diabetes Care<\/i> 19:1031.","DOI":"10.2337\/diacare.19.9.1031a"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Rowley MJ, Mackay IR, Chen QY, Knowles WJ, Zimmet PZ (1992) Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. <i>Diabetes<\/i> 41:548-551.","DOI":"10.2337\/diab.41.4.548"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, et al. (1992) Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. <i>J Clin Invest<\/i> 89:283-292.","DOI":"10.1172\/JCI115573"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Baekkeskov S, Landin M, Kristensen JK, Srikanta S, Bruining GJ, et al. (1987) Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. <i>J Clin Invest<\/i> 79:926-934.","DOI":"10.1172\/JCI112903"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Borg H, Gottsater A, Fernlund P, Sundkvist G (2002) A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. <i>Diabetes<\/i> 51:1754-1762.","DOI":"10.2337\/diabetes.51.6.1754"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, et al. (1994) Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. <i>Diabetes<\/i> 43:80-86.","DOI":"10.2337\/diab.43.1.80"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Buzzetti R, Di Pietro S, Giaccari A, Petrone A, Locatelli M, et al. (2007) High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. <i>Diabetes Care<\/i> 30:932-938.","DOI":"10.2337\/dc06-1696"},{"key":"13","unstructured":"13. Irie J, Maruyama T, Funakoshi S, Kasuga A, Iwasaki R, et al. (2002) A Case of Noninsulin-Dependent Diabetes Mellitus with Increasing Glutamic Acid Decarboxylase 65 Antibody Titer Accompanied by Graves&rsquo; Disease. <i>Tonyobyo (Diabetes) <\/i>45:187-190 (In Japanese)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kahara T, Takamura T, Otoda T, Ishikura K, Matsushita E (2009) Transient anti-GAD antibody positivity and acute pancreatitis with pancreas tail swelling in a patient with susceptible haplotype for type 1 diabetes mellitus. <i>Intern Med<\/i> 48:1897-1899.","DOI":"10.2169\/internalmedicine.48.2393"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Fabris P, Betterle C, Floreani A, Greggio NA, de Lazzari F, et al. (1992) Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. <i>Lancet<\/i> 340:548.","DOI":"10.1016\/0140-6736(92)91744-S"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nakamura M, Nishida W, Yamada Y, Chujo D, Watanabe Y, et al. (2008) Insulin administration may trigger pancreatic beta-cell destruction in patients with type 2 diabetes. <i>Diabetes Res Clin Pract<\/i> 79:220-229.","DOI":"10.1016\/j.diabres.2007.08.031"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nishida W, Nagata M, Imagawa A, Hanafusa T, Ohashi J, et al. (2014) Insulin administration may trigger type 1 diabetes in Japanese type 2 diabetes patients with type 1 diabetes high-risk HLA class II and the insulin gene VNTR genotype. <i>J Clin Endocrinol Metab<\/i> 99:E1793-1797.","DOI":"10.1210\/jc.2014-1759"},{"key":"18","unstructured":"18. Itoh Y, Fujita A, Tujimura F, Nakashima K, Miyake T (2010) GAD Antibody Seroconversion after Initiation of Insulin Therapy Followed by Elevation of the Antibody Titer in a Type 2 Diabetic Patient. <i>Tonyobyo (Diabetes) <\/i>53:10-14 (In Japanese)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, et al. (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. <i>Nature<\/i> 435:220-223.","DOI":"10.1038\/nature03523"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kent SC, Chen Y, Bregoli L, Clemmings SM, Kenyon NS, et al. (2005) Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. <i>Nature<\/i> 435:224-228.","DOI":"10.1038\/nature03625"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Butler MH, Solimena M, Dirkx R, Jr., Hayday A, De Camilli P (1993) Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. <i>J Exp Med.<\/i> 178:2097-2106.","DOI":"10.1084\/jem.178.6.2097"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kim J, Namchuk M, Bugawan T, Fu Q, Jaffe M, et al. (1994) Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. <i>J Exp Med.<\/i> 180:595-606.","DOI":"10.1084\/jem.180.2.595"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Wagner R, McNally JM, Bonifacio E, Genovese S, Foulis A, et al. (1994) Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies. <i>Diabetes<\/i> 43:851-856.","DOI":"10.2337\/diab.43.7.851"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kobayashi T, Tanaka S, Okubo M, Nakanishi K, Murase T, et al. (2003) Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes. <i>J Clin Endocrinol Metab<\/i> 88:4768-4775.","DOI":"10.1210\/jc.2002-021529"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. van Deutekom AW, Heine RJ, Simsek S (2008) The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus. <i>Diabet Med<\/i> 25:117-125.","DOI":"10.1111\/j.1464-5491.2007.02316.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tanaka S, Okubo M, Nagasawa K, Takizawa S, Ichijo M, et al. (2015) Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin-dependent (type 1) diabetes (SPIDDM). <i>Diabetol Int<\/i>:1-11.","DOI":"10.1007\/s13340-015-0211-5"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kasuga A, Maruyama T, Nakamoto S, Ozawa Y, Suzuki Y, et al. (1999) High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients. <i>J Autoimmun<\/i> 12:131-135.","DOI":"10.1006\/jaut.1998.0261"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/62\/12\/62_EJ15-0378\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T20:42:29Z","timestamp":1498250549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/62\/12\/62_EJ15-0378\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej15-0378","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}